Category: Nuclear medicine

The incidence of adverse reactions to radiopharmaceuticals is low, estimated at about 2 per 100,000 administrations [1.7.3]. This article explores the question, 'What are the dangers of radiopharmaceuticals?', examining the risks versus the substantial benefits of these medical tools.

Over 50 million nuclear medicine procedures are performed globally every year, all of which utilize a radioactive tracer. Understanding **how does radioactive tracer leave the body** is crucial for both patient safety and interpreting diagnostic results, as it occurs through a combination of biological excretion and radioactive decay.